Dergiler / Cyprus Journal of Medical Sciences / 2019 / Cilt: 4 - Sayı: 3

Leukocytoclastic Vasculitis: A Retrospective Analysis of 57 Cases

Sayfa
242–246
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION In clinical practice, it is important to keep in mind that although LCV is usually confined to the blood vessels of the skin, a detailed evaluation of the patients is required to detect the underlying causes and systemic involvement.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cutaneous small vessel vasculitis (CSVV) is a small vessel vasculitis affecting the skin primarily, but may be associated with larger systemic vasculitis or extra cutaneous involvement.
📊
Temel Bulgular & Veri:MATERIALS and METHODS In this retrospective study, the records of 57 patients with LCV from 2013 to 2017 managed at the Department of Dermatology were reviewed.
💡
Sonuç & Katkı:CONCLUSION In clinical practice, it is important to keep in mind that although LCV is usually confined to the blood vessels of the skin, a detailed evaluation of the patients is required to detect the underlying causes and systemic involvement.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Cutaneous small vessel vasculitis (CSVV) is a small vessel vasculitis affecting the skin primarily, but may be associated with larger systemic vasculitis or extra cutaneous involvement. The clinical hallmark is palpable purpura usually involving the lower extremities. Although CSVV can be induced by drugs, infections, connective tissue diseases, and malignancies, it can also be idiopathic. The aim of the present study was to analyze patients with cutaneous leukocytoclastic vasculitis (LCV) to determine disease characteristics. MATERIALS and METHODS In this retrospective study, the records of 57 patients with LCV from 2013 to 2017 managed at the Department of Dermatology were reviewed. A detailed evaluation of the data was done to determine demographic characteristics, etiological factors, clinical signs and symptoms, and treatment options. RESULTS The study included 39 female and 18 male patients. The median age of the patients was 55 years. The majority of patients (46, 80.7%) were classified as CSVV. Almost half of the cases (25, 43.9%) were idiopathic, but the most common cause was simultaneous infection and drug usage (12, 21%). The most common cutaneous manifestation was palpable purpura (21, 36.8%) involving the lower extremities (40, 70.2%). The most common extra cutaneous manifestation was joint involvement presenting as arthritis and/or arthralgia (15, 26.3%). The most frequent laboratory abnormality was an elevated C-reactive protein (40, 70.2%). CONCLUSION In clinical practice, it is important to keep in mind that although LCV is usually confined to the blood vessels of the skin, a detailed evaluation of the patients is required to detect the underlying causes and systemic involvement.

🔖

Bu Makaleye Atıf Yap

KARAOSMANOĞLU, N., ÇETİNKAYA, P., KARAASLAN, E. (2019). Leukocytoclastic Vasculitis: A Retrospective Analysis of 57 Cases. Cyprus Journal of Medical Sciences, Cilt: 4 - Sayı: 3, 242–246. https://ajindex.com/articles/153103

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Chung L, Kea B, Fiorentino Df. Cutaneous Vasculitis. In: Bolognia Jl, Jorizzo Jl, Rapini Rp, Editors. Dermatology. 2nd Ed. St. Louis (Mo): Elsevier Limited; 2008. P. 347-67
  2. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis introduction. Arthritis Rheum 1990; 33(8): 1065-7. [CrossRef] 3. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised ınternational chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65(1): 1-11. [CrossRef] 4. Goeser MR, Laniosz V, Wetter DA. A Practical Approach to the Diagnosis, Evaluation, and Management of Cutaneous Small-Vessel Vasculitis. Am J Clin Dermatol 2014; 15(4): 299-306. [CrossRef] 5. Shavit E, Alavi A, Sibbald RG. Vasculitis-what do we have to know? a review of literature. Int J Low Extrem Wounds 2018; 17(4): 218-26. [CrossRef] 6. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore) 1998; 77(6): 403-18. [CrossRef] 7. Chua SH, Lim JT, Ang CB. Cutaneous vasculitis seen at a skin referral centre in Singapore. Singapore Med J 1999; 40(3): 147-50
  3. Garcia-Porrua C, Gonzalez-Gay MA, Lopez-Lazaro L. Drug associated cutaneous vasculitis in adults in northwestern Spain. J Rheumatol 1999; 26(9): 1942-4
  4. Arora A, Wetter DA, Gonzalez-Santiago TM, Davis MD, Lohse CM. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in olmsted county, Minnesota. Mayo Clin Proc 2014; 89(11): 1515-24. [CrossRef] 10. Al-Mutairi N. Spectrum of cutaneous vasculitis in adult patients from the Farwaniya region of Kuwait. Med Princ Pract 2008; 17(1): 43-8. [CrossRef] 11. Tai YJ, Chong AH, Williams RA, Cumming S, Kelly RI. Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis. Australas J Dermatol 2006; 47(2): 92-6. [CrossRef] 12. Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol 2006; 45(1): 3-13. [CrossRef] 13. Jessop SJ. Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. Br J Rheumatol 1995; 34(10): 942-5. [CrossRef] 14. Sais G, Vidaller A, Jucgla A, Servitje O, Condom E, Peyri J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol 19